Looking ahead, the industry's focus is shifting toward long-acting formulations, precision dosing, digital patient monitoring, and personalized treatment strategies that improve adherence while minimizing adverse effects
In addition, most insurance companies do not cover any or all GLP-1 medications unless patients meet very specific criteria, leaving many individuals to pay hundreds of dollars a month out of pocket (KFF, 2024)
Abbreviations MASLD : Metabolic dysfunction-associated steatotic liver disease MASH : Metabolic dysfunction-associated steatohepatitis T2DM : Type 2 diabetes mellitus GLP-1 RAs : Glucagon-like peptide-1 receptor agonists GIP : Glucose-dependent insulinotropic polypeptide GCG : Glucagon AACE : American Association of Clinical Endocrinology AASLD : American Association for the Study of the Liver Diseases F2 : Fibrosis grade 2 ABCD : Adiposity-based chronic diseases EASO : European Association for the Study of Obesity VAT : Visceral adipose tissue FFA : Free fatty acids HSC : Hepatic stellate cells FDA : Food and drug administration F3 : Fibrosis grade 3 AST : Aspartate aminotransferase ALT : Alanine aminotransferase GGT : Gamma-glutamyl transferase NAFLD : Non-alcoholic fatty liver-disease LFC : Liver fat content MRI-PDFF : Magnetic resonance imaging derived proton density fat fraction ELF : Enhanced liver fibrosis FIB-4 : Fibrosis-4 index F1 : Fibrosis grade 1 NAS : NAFLD activity score AE : Adverse event SAE : Serious adverse event EMA : European Medicine Agency FGF21 : Fibroblast growth factor 21 MetALD : Metabolic dysfunction and alcohol-related liver disease References Le MH, Le DM, Baez TC, Wu Y, Ito T, Lee EY, Lee K, Stave CD, Henry L, Barnett SD, Cheung R, Nguyen MH
The evidence is strongest for semaglutide and tirzepatide
Many communities offer sharps disposal programs or mail-back options
Understanding magnesium's role in the broader electrolyte picture helps inform supplementation decisions
30075-9/asset/dbc36aef-b825-4231-a980-7d1590b8f4e9/main.assets/gr2b_lrg.jpg)
.png)
